BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• 

  Drug Development

  Aimmune Jumps On Phase III Peanut Allergy Trial Data

  Aimmune Therapeutics announced late-stage trial results that showed its peanut allergy therapy was effective in more than 67 percent of juvenile patients.

  February 20, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  FDA

  FDA Gives AstraZeneca’s Imfinzi the Nod for New Lung Cancer Indication

  The U.S. Food and Drug Administration (FDA) approved AstraZeneca’s Imfinzi to treat patients with unresectable Stage III non-small cell lung cancer (NSCLC).

  February 20, 2018

   · 

  3 min read

   · 

  Mark Terry
• 

  Biotech Bay

  Dynavax Secures $175 Million in Funding to Support Launch of Recently Approved Heplisav-B

  Dynavax announced it has secured a $175 million non-dilutive term loan agreement to commercialize Heplisav-B.

  February 20, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  AbbVie and Voyager Therapeutics Launch $1.2 Billion+ Alzheimer’s Partnership

  AbbVie and Voyager Therapeutics inked a collaboration deal to develop treatments for Alzheimer’s disease and other neurodegenerative diseases.

  February 20, 2018

   · 

  3 min read

   · 

  Mark Terry
• 

  Deals

  J&J Could Explore Potential $2B Sale of Sterilization Products Division

  Life sciences giant Johnson & Johnson may be shopping around its sterilization products division.

  February 20, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Deals

  PDL BioPharma Gives Up on Acquiring Neos Therapeutics

  Nevada-based PDL BioPharma, Inc. said it will no longer pursue a proposed acquisition of Neos Therapeutics.

  February 20, 2018

   · 

  2 min read

   · 

  Alex Keown
• 

  Biotech Bay

  Federal Court Overturns Gilead Sciences and Merck Patent Dispute

  Federal court judge orders Merck to repay $2.5 Billion to Gilead in overturned patent decision.

  February 20, 2018

   · 

  2 min read

   · 

  Mark Terry
• Business

  CSI Laboratories Announces Construction of New Cancer Diagnostics Laboratory in Florida

  CSI Laboratories, a national cancer diagnostics laboratory based in Atlanta, Georgia, is expanding its operations to Jupiter, Florida.

  February 20, 2018

   · 

  2 min read
• Policy

  Acorda Announces FDA Acceptance of New Drug Application for INBRIJA™ (levodopa inhalation powder)

  INBRIJA is an investigational inhaled levodopa treatment for symptoms of OFF periods in people with Parkinson’s disease taking a carbidopa/levodopa regimen.

  February 20, 2018

   · 

  5 min read
• Genetown

  MilliporeSigma Receives Two More Patents for CRISPR Technology

  MilliporeSigma announced that the Korean Intellectual Property Office and the Israel Patent Office have each granted patent applications for the company’s CRISPR technology used in a genomic-integration method for eukaryotic cells.

  February 20, 2018

   · 

  4 min read